German Startup Offers Cryogenic Freezing of Bodies for Future Revival 

A Berlin-based startup, Tomorrow Bio, is pioneering cryonics in Europe by offering to freeze deceased individuals in liquid nitrogen, preserving them until science can revive and rejuvenate them. The cost is hefty: €200,000 for whole-body preservation and €75,000 for the brain-only option. 

Tomorrow Bio has already frozen six humans and five pets, and over 650 people have enrolled through membership plans, often funded by life insurance policies. The company operates ambulances in Berlin, Amsterdam, and soon Zurich, to promptly start the cryopreservation process, cooling bodies to minus 80°C for transport to a storage facility in Rafz, Switzerland. 

The process involves replacing bodily fluids with medical-grade antifreeze and cooling bodies to -320°F before long-term storage. Tomorrow Bio claims to be the only company providing “field cryoprotection,” initiating the process immediately after legal death using specialized ambulances. 

Despite initial interest, Tomorrow Bio has yet to turn a profit. The company aims to expand to the US in 2025, with future plans for Latin America and Asia. The concept garners interest from varied motivations, but the question of rejuvenation and future reanimation technology remains speculative

. 

While the idea of cryonics has been around since the 1960s, it remains controversial. Critics argue that the technology to revive frozen bodies does not yet exist and may never be developed. However, proponents believe that preserving bodies now gives future generations the opportunity to bring them back to life when science catches up.

As the debate continues, Tomorrow Bio’s venture into cryonics represents a bold step into a future where death may not be the end, but rather a pause until science finds a way to reverse it.